2013
DOI: 10.1016/j.ejps.2013.04.019
|View full text |Cite
|
Sign up to set email alerts
|

Viscosity of high concentration protein formulations of monoclonal antibodies of the IgG1 and IgG4 subclass – Prediction of viscosity through protein–protein interaction measurements

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
97
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 115 publications
(101 citation statements)
references
References 41 publications
3
97
0
Order By: Relevance
“…7 B. Orientation-dependent patchy interactions in proteins are captured crudely, at best, in the BSS model. We emphasize that these data invalidate the assumption that the interaction potential of mean force of protein solutions is universally independent of concentration (128,129).…”
Section: Resultsmentioning
confidence: 92%
“…7 B. Orientation-dependent patchy interactions in proteins are captured crudely, at best, in the BSS model. We emphasize that these data invalidate the assumption that the interaction potential of mean force of protein solutions is universally independent of concentration (128,129).…”
Section: Resultsmentioning
confidence: 92%
“…A strong correlation has been reported between decreasing values of k D or increasing values of r h,apparent measured using DLS at low antibody concentration and increased viscosity at high concentration [27]. …”
Section: Applicationsmentioning
confidence: 99%
“…Thus, for antibody biopharmaceuticals, where doses of up to several mg/kg body weight is often desirable, highly concentrated solutions (up to several hundreds of mg/mL) may be required to deliver the necessary dose. At high concentrations, protein solutions (in the range of ≥100 mg/mL) can exhibit unwanted properties, such as increased levels of aggregation and viscosity levels that exceed the mechanical limits of syringes and autoinjector devices to deliver the dose [3][4][5][6]. As aggregation and high viscosity can affect biopharmaceutical manufacturing, efficacy, and administration route, it is critical to understand how and why these phenomena occur, in order to minimize or eliminate them [3,7,8].…”
Section: Introductionmentioning
confidence: 99%